Molecular-based assays aid diagnosis and treatment decisions
PSA levels found to be a ‘significant predictor’
Future biomarker test could guide treatment, surveillance decisions
Survival for months or several years while delaying treatment is possible
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Outpatient surgery using permanent implants is an option for BPH
Findings have implications for patients, providers, policymakers
Case presentation shows techniques
Genomic testing isn’t just for low-risk tumors
Benefits include patient education, marketing
Inhibition could lead to treatments
Advertisement
Advertisement